PubMed · 1758723
[Vancomycin in 1991: current status and perspectives].
Abstract
Vancomycin is a narrow-spectrum glycopeptide antibiotic which is primarily active against Gram-positive organisms. Bacterial resistance develops rarely due to its numerous modes of action. The mode of action of vancomycin involves the inhibition of peptidoglycan synthesis. Vancomycin forms a stoichiometric complex with the peptidoglycan precursor UDP-N-acetylmuramyl pentapeptide by forming hydrogen bonds. In patients with renal insufficiency vancomycin clearance is reduced and elimination half-life prolonged. Vancomycin is the drug of choice in the treatment of methicillin-resistant staphylococcal infections and in the treatment of Gram-positive endocarditis and has been used as alternative therapy in the treatment or prophylaxis of Gram-positive infections in penicillin-allergic patients.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A Casetta, E Bingen, N Lambert-Zechovsky. 1991. [Vancomycin in 1991: current status and perspectives].. https://pubmed.ncbi.nlm.nih.gov/1758723/
Cite the original work for its findings. Save a collection to share your selection of sources.